- 73% Sales Growth Over Same Quarter Last Year -
- 20% U.S. Sequential Quarterly Sales Increase -
- FY08 Revenue Projection Raised -
- Preliminary FY09 Revenue Outlook Provided -
- Conference Call to be Held at 10:00 a.m. Central Time Today -
MINNEAPOLIS, Nov. 1 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) today reported record net sales of $3.0 million for the second quarter of fiscal 2008 ended September 30, 2007, up 73% from $1.8 million in the year ago quarter. Excluding the translation impact of fluctuations in foreign currency exchange rates, sales during the second fiscal quarter increased by approximately 66%.
For the three months ended September 30, 2007, sales to customers in the U.S. increased to $1.2 million from $253,000 in the year ago quarter. Sales for the three months ended September 30, 2007 represent a sequential increase of 20% from $1.0 million in the first quarter of fiscal 2008. Sales to customers outside the U.S. for the three months ended September 30, 2007 were $1.8 million, representing a $318,000 or 21% increase, compared to $1.5 million in the year ago quarter. Excluding the translation impact of fluctuations in foreign currency exchange rates, sales to customers outside of the U.S. increased by approximately 13%.
David B. Kaysen, Uroplasty's President and CEO said, "We are very
encouraged by our record revenue performance this year and our sequential
quarterly sales growth in the U.S. Both achievements are due to the growing
market acceptance of our Urgent(R) PC system, which contributed to our
record performance this year. During the second quarter, we surpassed 200
active customers in the U.S. for our Urgent PC system and doctors are
excited about the benefits it provides to their patients. We believe that
our Urgent PC system, which received regulatory approvals in the summer of
2006, is the only FDA-approved non-surgical nerv
|SOURCE Uroplasty, Inc.|
Copyright©2007 PR Newswire.
All rights reserved